CYSLTR2 and neoplasm: Assessing with immunohistochemistry, gastric cancer tissue showed significantly increased immunoreactive score of CysLT1R than tumor-free gastric mucosa; the intestinal type had more CysLT1R and CysLT2R expression than the diffuse type [103].